期刊的影响因子--文章列表

期刊文章列表
Xiaojing Chu，Yu Zhang，Sijin Cheng（Changping Laboratory）.Heterogeneity of tumor-infiltrating myeloid cells in era of single-cell genomics[J].Chinese Journal of Cancer Research,2022,第6期 Qianru Li¹，Maomao Cao¹，Lin Lei²，Fan Yang¹，He Li¹，Xinxin Yan¹，Siyi He¹，Shaoli Zhang¹，Yi Teng¹，Changfa Xia¹，Wanqing Chen¹（Office of Cancer Screening,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College；Department of Cancer Prevention and Control,Shenzhen Center for Chronic Disease Control）.Burden of liver cancer：From epidemiology to prevention[J].Chinese Journal of Cancer Research,2022,第6期 Xiaohong Han¹，Mingzhi Zhang²，Huaqing Wang，Qingyuan Zhang⁴，Wei Li⁵，Miaowang Hao⁶，Yuhuan Gao⁷，Jie Jin⁸，Hanyun Ren⁹，Yun Tang¹⁰，Xiaonan Hong¹¹，Xiaoyan Ke¹²，Hang Su¹³，Lin Gui¹⁴，Jianmin Luo¹⁵，Liangzhi Xie¹⁶，Wenlin Gai¹⁶，Yuankai Shi¹⁴（Clinical Pharmacology Research Center,Peking Union Medical College Hospital,State Key Laboratory of Complex Severe and Rare Diseases,NMPA Key Laboratory for Clinical Research and Evaluation of Drug,Beijing Key Laboratory of Clinical PK ＆amp;PD Investigation for Innovative Drugs,Chinese Academy of Medical Sciences ＆amp;Peking Union Medical College；Department of Oncology,the First Affiliated Hospital of Zhengzhou University；Department of Medical Oncology,Tianjin People’s Hospital；Department of Medical Oncology,Harbin Medical University Cancer Hospital；Oncology Department of Cancer Center,the First Hospital of Jilin University；Department of Hematology,Tangdu Hospital,Air Force Medical University；Department of Hematology,the Fourth Hospital of Hebei Medical University；Department of Hematology,the First Affiliated Hospital of Zhejiang University；Department of Hematology,Peking University First Hospital；Department of Hematology,West China Hospital,Sichuan University；Department of Medical Oncology,Fudan University Shanghai Cancer Center；Department of Hematology,Peking University Third Hospital；Department of Lymphoma,the Fifth Medical Center of PLA General Hospital；Department of Medical Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences ＆amp;Peking Union Medical College,Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs；Department of Hematology,the Second Hospital of Hebei Medical University；Beijing Engineering Research Center of Protein and Antibody,Sinocelltech Ltd.）.A multi-center, open-label, randomized, parallel-controlled phase II study comparing pharmacokinetic, pharmacodynamics and safety of ripertamab（SCT400） to rituximab（Mab Thera^?） in patients with CD20-positive B-cell non-Hodgkin lymphoma[J].Chinese Journal of Cancer Research,2022,第6期 Shen Li¹，Fei Shan¹，Xiaotian Zhang³，Yongheng Li⁴，Yu Sun⁵，Lei Tang⁶，Qi Wu⁷，Wenjing Yang⁸，Jincheng Yang⁸，Yu An⁸，Ming Deng⁸，Jiafu Ji¹（Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Gastrointestinal Cancer Center；Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Gastrointestinal Oncology；Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Radiotherapy；Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Pathology；Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Radiology；Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Endoscopy Center;Peking University Cancer Hospital ＆ Institute；Office for Cancer Diagnosis and Treatment Quality Control, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College）.Chinese quality control indices for standardized diagnosis and treatment of gastric cancer（2022 edition）[J].Chinese Journal of Cancer Research,2022,第6期 Binghe Xu¹，Huiping Li²，Zefei Jiang³，Lin Gu⁴，Jinhai Tang⁵，Hui Xie⁵，Yueyin Pan⁶，Yunjiang Liu⁷，Shude Cui⁸，Xiaojia Wang⁹，Li Cai¹⁰，Yiqiong Zhang¹¹，Huadong Zhao¹²，Zhimin Shao¹³（Department of Medical Oncology,National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College；Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Breast Oncology,Peking University Cancer Hospital ＆amp;Institute；Department of Breast Cancer,the Fifth Medical Center of Chinese PLA General Hospital；Department of Breast Cancer,Tianjin Cancer Institute and Hospital；Department of Breast Cancer,Jiangsu Provincial Hospital；Department of Breast Cancer,the First Affiliated Hospital of China University of Science and Technology；Department of Breast Cancer,the Fourth Hospital of Hebei Medical University；Department of Breast Cancer,Henan Cancer Hospital；Department of Breast Cancer,Zhejiang Cancer Hospital；Department of Breast Cancer,Harbin Medical University Cancer Hospital；Department of Clinical Development,Pfizer (China) R＆amp;D Co.Ltd；Department of Statistics,Pfizer (China) R＆amp;D Co.Ltd；Department of Breast Surgery,Shanghai Cancer Center/Cancer Institute,Shanghai Medical College,Fudan University）.Adjuvant tamoxifen switched to exemestane treatment in postmenopausal women with estrogen receptor-positive early breast cancer：A pragmatic, multicenter, and prospective clinical trial in China[J].Chinese Journal of Cancer Research,2022,第6期 Erica Sakamoto，Adriana Vaz Safatle-Ribeiro，Ulysses Ribeiro Jr（Department of Gastroenterology,Instituto do Cancer do Estado de São Paulo,Hospital das Clinicas,Faculdade de Medicina,Universidade de São Paulo,(ICESP-HCFMUSP)）.Advances in surgical techniques for gastric cancer：Indocyanine green and near-infrared fluorescence imaging. Is it ready for prime time?[J].Chinese Journal of Cancer Research,2022,第6期 Paulo Pimentel de Assump??o¹，Rommel Rodrigues Burbano^1,2（Universidade Federal do Pará,Núcleo de Pesquisas em Oncologia；Hospital Ophir Loyola,Laboratório de Biologia Molecula）.Advances in gastric cancer research will light the way to control this cancer[J].Chinese Journal of Cancer Research,2022,第6期 Jiaran Zhang，Lu Si，Jun Guo（Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Melanoma ＆amp;Sarcoma,Peking University Cancer Hospital ＆amp;Institute）.Comments on National guidelines for diagnosis and treatment of melanoma 2022 in China（English version）[J].Chinese Journal of Cancer Research,2022,第6期 Eider Talavera-Urquijo¹，Bas P.L.Wijnhoven²（Department of Surgery,University Hospital of Donostia；Department of Surgery,Erasmus University Medical Centre Rotterdam）.Evolution of laparoscopic gastrectomy for cancer in the East and West[J].Chinese Journal of Cancer Research,2022,第6期 Yuan Feng，Nan Wu（Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Thoracic Surgery II,Peking University Cancer Hospital ＆amp;Institute）.Comments on National guidelines for diagnosis and treatment of esophageal carcinoma 2022 in China（English version）[J].Chinese Journal of Cancer Research,2022,第6期 Marina Alessandra Pereira¹，Marcus Fernando Kodama Pertille Ramos¹，André Roncon Dias¹，Leonardo Cardili²，Rafael Dyer Rodrigues de Moraes²，Renan Ribeiro E Ribeiro²，Venancio Avancini Ferreira Alves²，Bruno Zilberstein¹，Evandro Sobroza de Mello²，Ulysses Ribeiro Jr¹（Department of Gastroenterology,Instituto do Cancer do Estado de São Paulo,Hospital das Clinicas,Faculdade de Medicina,Universidade de São Paulo,(ICESP-HCFMUSP) São Paulo；Department of Pathology,Instituto do Cancer do Estado de São Paulo,Hospital das Clinicas,Faculdade de Medicina,Universidade de São Paulo,(ICESP-HCFMUSP) São Paulo）.Prognostic implications of tumor-infiltrating lymphocytes in association with programmed cell death ligand 1 expression in remnant gastric cancer[J].Chinese Journal of Cancer Research,2022,第6期 Kemin Jin，Baocai Xing（Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Hepatobiliary and Pancreatic Surgery Unit I,Peking University Cancer Hospital ＆amp;Institute）.Comments on National guidelines for diagnosis and treatment of pancreatic cancer 2022 in China（English version）[J].Chinese Journal of Cancer Research,2022,第6期 Eiji Nomura（Department of Gastroenterological and General Surgery,Tokai University Hachioji Hospital）.Postoperative functional evaluation of gastrectomy for gastric cancer[J].Chinese Journal of Cancer Research,2022,第6期 Xiaohong Han，Mingzhi Zhang，Huaqing Wang，Qingyuan Zhang，Wei Li，Miaowang Hao，Yuhuan Gao，Jie Jin，Hanyun Ren，Yun Tang，Xiaonan Hong，Xiaoyan Ke，Hang Su，Lin Gui，Jianmin Luo，Liangzhi Xie，Wenlin Gai，Yuankai Shi（Clinical Pharmacology Research Center，Peking Union Medical College Hospital，State Key Laboratory of Complex Severe and Rare Diseases，NMPA Key Laboratory for Clinical Research and Evaluation of Drug，Beijing Key Laboratory of Clinical PK&PD Investigation for Innovative Drugs，Chinese Academy of Medical Sciences&Peking Union Medical College，Beijing 100730，China；Department of Oncology，the First Affiliated Hospital of Zhengzhou University，Zhengzhou 450052，China；Department of Medical Oncology，Tianjin People's Hospital，Tianjin 300121，China；Department of Medical Oncology，Harbin Medical University Cancer Hospital，Harbin 150081，China；Oncology Department of Cancer Center，the First Hospital of Jilin University，Changchun 130021，China；Department of Hematology，Tangdu Hospital，Air Force Medical University，Xi'an 710038，China；Department of Hematology，the Fourth Hospital of Hebei Medical University，Shijiazhuang 050011，China；Department of Hematology，the First Affiliated Hospital of Zhejiang University，Hangzhou 310003，China；Department of Hematology，Peking University First Hospital，Beijing 100034，China；Department of Hematology，West China Hospital，Sichuan University，Chengdu 610041，China；Department of Medical Oncology，Fudan University Shanghai Cancer Center，Shanghai 200032，China；Department of Hematology，Peking University Third Hospital，Beijing 100191，China；Department of Lymphoma，the Fifth Medical Center of PLA General Hospital，Beijing 100071，China；Department of Medical Oncology，National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital，Chinese Academy of Medical Sciences&Peking Union Medical College，Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs，Beijing 100021，China；Department of Hematology，the Second Hospital of Hebei Medical University，Shijiazhuang 050000，China；Beijing Engineering Research Center of Protein and Antibody，Sinocelltech Ltd.，Beijing 100176，China）.A multi-center, open-label, randomized, parallel-controlled phase Ⅱ study comparing pharmacokinetic, pharmacodynamics and safety of ripertamab (SCT400) to rituximab (MabThera?) in patients with CD20-positive B-cell non-Hodgkin lymphoma[J].中国癌症研究(英文版),2022,第6期 Paulo Pimentel de Assumpcao，Rommel Rodrigues Burbano.Advances in gastric cancer research will ght the way to control this cancer[J].中国癌症研究(英文版),2022,第6期 Qianru Li¹，Hongliang Wu²，Maomao Cao¹，He Li¹，Siyi He¹，Fan Yang¹，Xinxin Yan¹，Shaoli Zhang¹，Yi Teng¹，Changfa Xia¹，Ji Peng³，Wanqing Chen¹（Office of Cancer Screening,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College/Chinese Academy of Medical Sciences Key Laboratory for National Cancer Big Data Analysis and Implement；Department of Anesthesiology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College；Department of Cancer Prevention and Control,Shenzhen Center for Chronic Disease Control）.Colorectal cancer burden, trends and risk factors in China：A review and comparison with the United States[J].Chinese Journal of Cancer Research,2022,第5期 Yixin Qian^1,2，Ting Yang^1,2，Huan Liang²，Mi Deng^1,2,3（Peking University International Cancer Institute,Health Science Center,Peking University；School of Basic Medical Sciences,Health Science Center,Peking University；Peking University Cancer Hospital＆Institute,Peking University）.Myeloid checkpoints for cancer immunotherapy[J].Chinese Journal of Cancer Research,2022,第5期 Zhilong Wang¹，Yinkui Wang²，Xiaoting Li¹，Yanling Li¹，Zhaode Bu²，Zhongwu Li³，Yingshi Sun¹，Jiafu Ji²（Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing)；Department of RadiologyDepartment of Radiology；Center of Gastrointestinal SurgeryCenter of Gastrointestinal Surgery）.Correlation between imaging features on computed tomography and combined positive score of PD-L1 expression in patients with gastric cancer[J].Chinese Journal of Cancer Research,2022,第5期 mengyu feng，jingtao wei，keji，yinan zhang，heli yang，xiaojiang wu，ji zhang，zhaode bu，jiafu ji（Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Center of Gastrointestinal Cancer,Peking University Cancer Hospital＆Institute）.Characteristics of lymph node stations/basins metastasis and construction and validation of a preoperative combination prediction model that accurately excludes lymph node metastasis in early gastric cancer[J].Chinese Journal of Cancer Research,2022,第5期 national health commission of the people’s republic of china.National guidelines for diagnosis and treatment of malignant lymphoma 2022 in China （English version）[J].Chinese Journal of Cancer Research,2022,第5期 naiyi zhang，yunong gao（Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Gynecologic Oncology,Peking University Cancer Hospital＆Institute）.Comments on National guidelines for diagnosis and treatment of cervical cancer 2022 in China （English version）[J].Chinese Journal of Cancer Research,2022,第5期 khek yu ho（Department of Medicine,National University of Singapore）.Beyond images：Emerging role of Raman spectroscopy-based artificial intelligence in diagnosis of gastric neoplasia[J].Chinese Journal of Cancer Research,2022,第5期 Hao Wang¹，Jian Wang²，Xiang Wang³，Yiming Zhu⁴，Yuqing Sun^5,6，Xin Zhang^5,6，Xiaorong Hou⁷，Kun Zheng^5,6，Shaoyan Liu²，Yansong Lin^5,6（Department of Clinical Oncology,Qingdao Municipal Hospital,Qingdao University；Department of Head and Neck Surgical Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College；Department of Medical Oncology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College；Department of Radiation Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College；Department of Nuclear Medicine,State Key Laboratory of Complex Severe and Rare Diseases,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College；Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine；Department of Radiation Oncology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College）.Comments on National guidelines for diagnosis and treatment of thyroid cancer 2022 in China （English version）[J].Chinese Journal of Cancer Research,2022,第5期 yong yang（Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Department of Urology,Peking University Cancer Hospital＆Institute）.Comments on National guidelines for diagnosis and treatment of prostate cancer 2022 in China （English version）[J].Chinese Journal of Cancer Research,2022,第5期 Jiahui Chen^1,2，Zhaode Bu³，Jiafu Ji³（Department of Gastric Surgery,the Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital),Institute of Basic Medicine and Cancer (IBMC),Chinese Academy of Sciences；Key Laboratory of Prevention,Diagnosis and Therapy of Upper Gastrointestinal Cancer of Zhejiang Province；Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Center of Gastrointestinal Surgery,Peking University Cancer Hospital＆Institute）.Comments on National guidelines for diagnosis and treatment of gastric cancer 2022 in China （English version）[J].Chinese Journal of Cancer Research,2022,第5期 jeong ho song，sang-uk han（Department of Surgery,Ajou University School of Medicine）.Perspectives of laparoscopic surgery for gastric cancer[J].Chinese Journal of Cancer Research,2022,第5期 xinguang wang，zhaoqing fan（Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing),Breast Center,Peking University Cancer Hospital＆Institute）.Comments on National guidelines for diagnosis and treatment of breast cancer 2022 in China （English version）[J].Chinese Journal of Cancer Research,2022,第5期首页 1 2 3 下一页尾页共有3页，转到页

期刊文章列表